Peptilogics
Peptilogics is a clinical-stage biotechnology company that designs and develops novel peptide therapeutics. Through their computational platform, Peptilogics is radically altering drug discovery by not only uncovering new, previously unexplored chemical design space but also ensuring that each potential therapeutic is biologically viable and scalable to manufacture. Peptilogics' lead clinical-stage peptide therapeutic, PLG0206, is a novel, broad-spectrum anti-infective that has been granted FDA Orphan Drug Designation and Qualified Infectious Disease Product Designation for its initial focus on the treatment of prosthetic joint infections, an unmet medical need.
Domain
peptilogics.com
Country
United StatesIndustry
Artificial Intelligence (AI)Employees
11-50
Last Funding
$78.0M
Founded
2012
Tech Stack (28 technologies)
Frequently Asked Questions
What technologies does Peptilogics use?+
Peptilogics uses 28 technologies including cdnjs, Google Analytics, Google Tag Manager.
What industry is Peptilogics in?+
Peptilogics operates in the Artificial Intelligence (AI) industry.
Where is Peptilogics based?+
Peptilogics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026